Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

Preliminary data showed Novavax's non-mRNA JN.1 COVID-19 vaccine induced lower frequency and severity of short-term side ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $140.00.

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new pandemic surged around them. By a year later, 66 million American adults had ...

FILE PHOTO: TikTok app logo is seen in this illustration taken, August 22, 2022. REUTERS/Dado Ruvic/Illustration/File Photo 02 Apr 2025 01:51AM (Updated: 02 Apr 2025 06:48AM) ...

More than 85% of patients with small-cell lung cancer dosed with BioNTech’s investigational bispecific antibody BNT327 responded to the treatment, according to a mid-stage readout on Friday. The data, ...

In this article, we are going to look at where BioNTech SE (NASDAQ:BNTX) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market conditions ...

Companies like BioNTech, Moderna, and smaller players such as myNEO Therapeutics are at the forefront, using their expertise in mRNA technology, which was initially honed during the COVID-19 pandemic.

BioNTech has passed on Autolus Therapeutics’ dual targeting CAR-T cell therapy. One year after securing a chance to co-develop the prospect, BioNTech let the option expire as part of its ...

During the pandemic, the UK approved five vaccines for use, including one developed by Pfizer-BioNTech, which paved the way for mass vaccination. Dr Kitchin said finding out the vaccine was ...

My young patient cheerfully jumped down from the exam table following a routine checkup and reached for his mother’s hand. Then I asked if we could proceed with a vaccine that was recommended at his ...